Limitations of the algorithm for the SAFE biopsy: A noninvasive fibrosis measure in chronic hepatitis C
Mohammed Rashid, Jonathon D. Mitchell, Matthew E. Cramp, Timothy J. S. Cross – 23 December 2009
Mohammed Rashid, Jonathon D. Mitchell, Matthew E. Cramp, Timothy J. S. Cross – 23 December 2009
Wing‐Kin Syn, Ye Htun Oo – 23 December 2009
Sathish Kumar Natarajan, Kavitha R. Thangaraj, C. E. Eapen, Anup Ramachandran, Ashis Mukhopadhya, Mathews Mathai, Lakshmi Seshadri, Abraham Peedikayil, Banumathi Ramakrishna, Kunnissery A. Balasubramanian – 23 December 2009 – Acute fatty liver of pregnancy (AFLP) is a rare disorder which is fatal if not recognized and treated early. Delivery of the feto‐placental unit results in dramatic improvement in maternal liver function, suggesting a role for the placenta.
José A. Carrión, Ferran Torres, Gonzalo Crespo, Rosa Miquel, Juan‐Carlos García‐Valdecasas, Miquel Navasa, Xavier Forns – 23 December 2009 – Significant liver fibrosis (F ≥ 2) and portal hypertension (hepatic venous pressure gradient [HVPG] ≥ 6 mmHg) at 1 year after liver transplantation (LT) identify patients with severe hepatitis C recurrence. We evaluated whether repeated liver stiffness measurements (LSM) following LT can discriminate between slow and rapid “fibrosers” (fibrosis stage F2‐F4 at 1 year after LT).
Muhammad F. Dawwas, Rajesh Sivaprakasam, Andrew J. Butler, Neville V. Jamieson, Graeme J. Alexander – 23 December 2009
Maria Buti, Cecilia Cabrera, Rosendo Jardi, Luis Castells, Rafael Esteban – 23 December 2009
Kittichai Promrat, David E. Kleiner, Heather M. Niemeier, Elizabeth Jackvony, Marie Kearns, Jack R. Wands, Joseph L. Fava, Rena R. Wing – 23 December 2009 – Nonalcoholic steatohepatitis (NASH) is a chronic progressive liver disease that is strongly associated with obesity. Currently, there is no approved therapy for NASH. Weight reduction is typically recommended, but efficacy data are lacking.
Martin Roderfeld, Timo Rath, Robert Voswinckel, Christian Dierkes, Hartmut Dietrich, Daniel Zahner, Jürgen Graf, Elke Roeb – 23 December 2009 – Bone marrow (BM)‐derived stem cells and CD34+ fibrocytes are associated with fibrogenesis in several organs. In an Abcb4−/− mouse model for sclerosing cholangitis alpha‐smooth muscle actin‐positive (α‐SMA+) myofibroblasts are thought to play a pivotal role in hepatic fibrogenesis.
Shigeru Marubashi, Hiroaki Nagano, Eigoro Yamanouchi, Shogo Kobayashi, Hidetoshi Eguchi, Yutaka Takeda, Masahiro Tanemura, Noboru Maeda, Kaname Tomoda, Hayato Hikita, Shusaku Tsutsui, Yuichiro Doki, Masaki Mori – 23 December 2009 – In living donor liver transplantation (LDLT), bile duct reconstruction is often technically demanding due to the frequently anomalous anatomy of the bile duct, as well as the high incidence of biliary complications. A bile duct branch may also be accidentally left without anastomosis at the time of LDLT and found to be obstructed after surgery.
Bin Gao – 23 December 2009